A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

Clinical trial NCT05995782 · RECRUITING

Trial details

NCT number: NCT05995782
Sponsor: 1ST Biotherapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease Psychosis Amyotrophic Lateral Sclerosis (ALS)

Start date: 2023-12-20
Primary completion: 2024-12-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.